Results Analysis [Study As­sess­ment]

posted by Achievwin – US, 2021-08-17 21:26 (1419 d 19:21 ago) – Posting: # 22524
Views: 7,676

❝ 90% CI AUC: Lower limit - 98.35, Upper limit - 132.50, T/R ratio of AUC: 112.2

❝ 90% CI Cmax: Lower limit - 95.38, Upper limit - 127.80, T/R ratio of Cmax: 109.5


❝ Questions:

❝ 1. Primary reason for BE Failure?


Looking at your confidence intervals it looks like your ISCV computation may not be accurate, I am getting 33.6 for AUC. Your study is under powered!!!!!.

Assuming high bound of 34% ISCV and Ratio of 112 you 136 subjects (completers) for a standard 2x2 study design.

To improve probability of success go for 3-way (if your RLD CV is tight) or 4-way cross over replicated design with RSABE option. You have a shot at satisfying Bioequivalence.

Hope this helps

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,680 registered users;
69 visitors (0 registered, 69 guests [including 15 identified bots]).
Forum time: 16:48 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5